Biotechnology

The Challenges and Advantages of Decentralized Clinical Trials in an era of increasing complexities

Nate Hughes, MPH, MPP, M. Phil. Johns Hopkins Bloomberg School of Public Health Alumnus  A recent survey from Applied Clinical Trials noted that 76% of 252 sponsor respondents recognized that COVID-19 accelerated their adoption of decentralized clinical trials (or “DCT”) including wearable devices, protocol redesign, and investigator-facing technologies.  In May […]

The Challenges and Advantages of Decentralized Clinical Trials in an era of increasing complexities

Spotlight Series – In Record Time: COVID-19 Vaccines and FDA Expedited Timelines

  This lecture will focus on two areas: the first, on the regulatory context of Operation Warp Speed and a corresponding “snapshot” of the COVID-19 therapeutic clinical trials from the Clinical Research Organizations (CRO’s) that run them. COVID-19 vaccines have been developed in record time. Despite this, the process has

Spotlight Series – In Record Time: COVID-19 Vaccines and FDA Expedited Timelines

Coronavirus Disease-2019 Clinical Trial Case Studies Within the Biotechnology and Clinical Research Organizations Industry

Melanie K. Pearce, MBA, MPH1; Nathanael E. Hughes, MPH, MPP, MPhil2* 1Brock University, Niagara Region, 1812 Sir Isaac Brock Way, St. Catharines, ON, L2S 3A1, Canada 2George Clinical, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA *Corresponding author Nathanael E. Hughes, MPH, MPP, MPhil Director of

Coronavirus Disease-2019 Clinical Trial Case Studies Within the Biotechnology and Clinical Research Organizations Industry

Lessons from COVID-19 Clinical Trials

Lessons from COVID-19 Clinical Trials Nate Hughes, MPH, MPP  South San Francisco, CA.  November 20th, 2020 « Dear Dean Klag, Lisa, Marie, Nate I trust you are all doing great! I have been talking with couple of people including folks from CDC working with Ministry of Health in Liberia.  We are

Lessons from COVID-19 Clinical Trials

Chutes and Ladders: 38th Annual J.P. Morgan Healthcare Conference

Attracting upwards of 20,000+ people in biotech, health care, venture capital and investment banking, the 38th annual J.P. Morgan Healthcare Conference, in San Francisco, took place on January 13-16th, 2020, to pitch their companies, forge deals and discuss the future of the $3.5 trillion health sector.  I wanted to highlight

Chutes and Ladders: 38th Annual J.P. Morgan Healthcare Conference

Scroll to Top